Nutritional Supplementation in Head and Neck Cancers

Exclusion Criteria

• •1. Fed by nasogastric tube, gastrostomy or total parenteral nutrition
• •2. Cancer of the nasopharynx, thyroid or salivary gland
• •3. Life expectancy \<6 months.
• •4. A known hypersensitivity / allergy to the investigational product or to any ingredient in their formulations (e.g. Milk/Lactose, Fish).
• •5. Enrolment in any other clinical protocol or investigational study with an interventional agent or assessments that may interfere with study procedures.
• •6. Patients with untreated brain metastases (patients with previously resected and/or radiated brain metastases without neurologic symptoms are permitted).
• •7. Poorly controlled chronic illnesses or other inflammatory diseases (e.g. COPD, uncontrolled non-insulin dependent diabetes, rheumatoid arthritis).
• •8. In the investigators' opinion, patients who have medical conditions that could interfere with nutrient metabolism or absorption (e.g., short bowel syndrome, Crohn's disease, etc.)